Laboratory Centrifuge Market is Projected to Reach USD 2.1 Billion by 2032, Growing at a 2.4% CAGR

Micro Laboratory Centrifuges to Capture Nearly 3/5th Market Share Globally: Fact.MR Study

As per a recent report published by Fact.MR, the global laboratory centrifuge market is poised to grow at a CAGR of 2.5% from 2022 to 2032, expected to close at a valuation of US$ 2.1 billion. Rising complexities in the nature and incidence of multiple chronic and infectious ailments are prompting healthcare providers to investigate advanced therapeutic and diagnostic approaches, for which the deployment of sophisticated laboratory centrifuges is becoming important.

From 2015 to 2021, the market for Laboratory Centrifuge grew at a CAGR of 2.1%, closing at a value of US$ 1.6 Billion. As of 2022, the industry is likely to reach US$ 1.65 Billion. Laboratory centrifuges are highly sought after in biotechnological research, attributed to their exclusive properties, including high efficiency in separating suspended particles, easy sedimentation of cells and viruses, and isolation of macromolecules.

As the medical industry expands, there are increasingly more clinical trials and analytical tests requested for different lab procedures. With the demand for new labs and instruments, laboratory centrifuges will continue to increase. As a result of their cost-effective nature, they are highly demanded in the market.

For More Insights into the Market, Request a Sample of this Report:https://www.factmr.com/connectus/sample?flag=S&rep_id=5665

Key Takeaways from the Market Study:

• Global laboratory centrifuge market to flourish 1.3x from 2022-2032
• Micro laboratory centrifuges to be a top-selling category, capturing more than 3/5th market share
• By application, laboratory centrifuges for the hospitals to expand at a CAGR of 3.1%
• U.S to emerge as an opportunistic laboratory centrifuge market, documenting a 2.3% CAGR
• China to be a significant market, expected to be valued at US$ 500 Million in 2032
• Germany to document the highest value CAGR, registering a growth rate of 4%

“As the global incidence of chronic and infectious diseases multiplies, healthcare providers are discovering advanced therapeutic and diagnostic alternatives, which will spearhead the demand for laboratory centrifuges in the long run," comments a Fact.MR analyst.

Leading Players Driving Innovation in the Laboratory Centrifuge Market:

Thermo Fisher Scientific Inc.; Becton, Dickinson and Company; Kubota Corporation; Danaher Corporation; Andreas Hettich GmbH & Co. KG; QIAGEN; HERMLE Labortechnik GmbH; Koki Holdings Co. Ltd

Competitive Landscape:

The global market for Laboratory Centrifuge is characterized by the presence of multiple vendors, aiming to offer extensive consulting and integration services to clients. Additionally, enterprises are seeking out, specialized service providers, offering solutions tailor-made to suit their business objectives. In addition, the vendors are likely to leverage up-gradation and product differentiation to gain an edge over other competitors in the market.

• Thermo Fisher, a leading global provider of science-related services, acquired PPD, Inc., a leading provider of clinical research services to the pharmaceutical and biotech industries. This acquisition will help Thermo Fisher to expand its services for pharmaceutical and biotechnology companies.
• In June 2021, Quest Diagnostics completed the acquisition of Mercy’s Outreach Laboratory Services business. The transaction aims to increase access to innovative, high-quality, and affordable laboratory services to provide affordable patient care throughout the Midwest. Upon completing the acquisition, Quest will gain immediate access to a wider network of healthcare professionals in Kansas, Arkansas, Missouri, and Oklahoma.

Get Customization on this Report for Specific Research Solutions:https://www.factmr.com/connectus/sample?flag=S&rep_id=5665

Laboratory Centrifuge Market News:

Thermo Fisher Scientific, a world leader in science-related services, acquired PPD, Inc., a top pharmaceutical and biotech industry clinical research services provider. The acquisition will enable Thermo Fisher to broaden its services for pharmaceutical and biotechnology firms.

Quest Diagnostics finalized the acquisition of Mercy's Outreach Laboratory Services business in June 2021. The deal will enhance access to innovative, high-quality, and cost-effective laboratory services to offer affordable patient care across the Midwest. When Quest finalizes the acquisition, it will immediately have access to a broader network of healthcare professionals in Kansas, Arkansas, Missouri, and Oklahoma.

More Valuable Insights:

Fact.MR, in its new offering, presents an unbiased analysis of the global laboratory centrifuge market, presenting a historical analysis from 2015 to 2021 and forecast statistics for the period of 2022-2032.

The study reveals essential insights based on product type(multipurpose centrifuges, micro laboratory centrifuges, ultra-laboratory centrifuges and others) and application (biotechnology & pharmaceutical companies, academic & research institutes, hospitals, diagnostics and other applications) across seven major regions (North America, Latin America, Europe, East Asia, South Asia, Oceania and the Middle East & Africa). 

Check out More Related Studies Published by Fact.MR Research:

The global anticoagulant rodenticides market was valued at US$ 744.7 million in 2023 and expand at a CAGR of 3.4% to end up at US$ 1,075.7 million by 2034.

The global Silicone-free Emulsifiers market was valued at US$ 695.3 million in 2024 and has been forecast to expand at a noteworthy CAGR of 5.6% to end up at US$ 1,200.8 million by 2034.

The global machinable ceramics market is projected value at US$ 224.1 million in 2024 and expand at a CAGR of 7.8% to end up at US$ 476.7 million by 2034.

The global low-carbon fertilizer market was valued at US$ 3,433.2 million in 2024 and expand at a CAGR of 5.8% to end up at US$ 6,033.3 million by 2034.

The global polyester film market was calculated at US$ 32.2 billion in 2024 and has been forecast to expand at a noteworthy CAGR of 5.7% to end up at US$ 56.1 billion by 2034.